Annual report pursuant to Section 13 and 15(d)

2. Summary of Significant Accounting Policies (Details Narrative)

v3.19.1
2. Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Basis Of Presentation And Significant Accounting Policies [Line Items]    
Letter of credit $ 100,000  
Letter of credit purpose Required for operating lease in Lexington, Massachusetts.  
Impairment of indefinate lived intangible assets $ 0 $ 0
Impairment of goodwill 0 0
Impairment of long-lived assets $ 0 $ 0
Antidilutive shares 800,000 600,000
JSOP [Member]    
Basis Of Presentation And Significant Accounting Policies [Line Items]    
Awards outstanding 300,000 300,000
Accrued Program Expense [Member]    
Basis Of Presentation And Significant Accounting Policies [Line Items]    
Accrued program expense $ 200,000  
Deposits held with clinical trial vendors [Member]    
Basis Of Presentation And Significant Accounting Policies [Line Items]    
Deposits held with clinical trial vendors $ 400,000  
Deferred program expenses [Member]    
Basis Of Presentation And Significant Accounting Policies [Line Items]    
Deposits held with clinical trial vendors   $ 33,000